Current Liabilities
Total Current Liabilities
Bristol-Myers Squibb Total Current Liabilities decreased by 16.8% to $23.42B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 1.5%, from $23.77B to $23.42B. Over 5 years (FY 2020 to FY 2025), Total Current Liabilities shows an upward trend with a 4.2% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryLiquidity
SignalLower is better
VolatilityModerate
First reportedQ3 2015
Last reportedQ4 2025
How to read this metric
A rising trend relative to current assets may indicate tightening liquidity or increased operational leverage.
Detailed definition
The sum of all financial obligations and debts that are due to be settled within one year or one operating cycle. This i...
Peer comparison
Used in the calculation of the Current Ratio and Quick Ratio to assess a firm's short-term financial health relative to industry peers.
Metric ID:
total_current_liabilitiesHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $18.99B | $21.46B | $21.87B | $22.82B | $20.92B | $18.93B | $21.89B | $19.09B | $20.15B | $23.46B | $22.26B | $25.82B | $23.27B | $22.64B | $23.77B | $24.07B | $27.53B | $28.14B | $23.42B |
| QoQ Change | — | +13.0% | +1.9% | +4.4% | -8.4% | -9.5% | +15.6% | -12.8% | +5.6% | +16.4% | -5.1% | +16.0% | -9.9% | -2.7% | +5.0% | +1.2% | +14.4% | +2.2% | -16.8% |
| YoY Change | — | — | — | — | +10.1% | -11.8% | +0.1% | -16.4% | -3.7% | +23.9% | +1.7% | +35.3% | +15.5% | -3.5% | +6.8% | -6.8% | +18.3% | +24.3% | -1.5% |
Range$18.93B – $28.14B
CAGR+4.8%
Avg YoY Growth+6.2%
Median YoY Growth+1.7%
Total Current Liabilities at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's total current liabilities?
- Bristol-Myers Squibb (BMY) reported total current liabilities of $23.42B in Q4 2025.
- How has Bristol-Myers Squibb's total current liabilities changed year-over-year?
- Bristol-Myers Squibb's total current liabilities decreased by 1.5% year-over-year, from $23.77B to $23.42B.
- What is the long-term trend for Bristol-Myers Squibb's total current liabilities?
- Over 5 years (2020 to 2025), Bristol-Myers Squibb's total current liabilities has grown at a 4.2% compound annual growth rate (CAGR), from $19.08B to $23.42B.
- What does total current liabilities mean?
- The total amount of money the company owes to others that is due within one year.